Cargando…

Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells

Non-small cell lung cancer (NSCLC) is one of the most common malignancies worldwide. The use of a combination of chemotherapy drugs and zinc oxide nanoparticles (ZnO-NPs), which have proven to induce tumor-selective cell death, reduce the drug resistance and reduce the side effects in vitro. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chenping, Du, Wenxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803530/
https://www.ncbi.nlm.nih.gov/pubmed/33232271
http://dx.doi.org/10.18632/aging.104187

Ejemplares similares